Evolution of Multitarget Strategies for Alzheimer's Disease: From Cholinergic Inhibition to Network-Oriented Therapeutic Design (2006-2025).

Mella J, Vega-Muñoz A, Soto M, Moraga D, Campanini-Salinas J, Sandoval-Obando E, Contreras-Barraza N, Salazar-Sepúlveda G, Salas-Guzmán N, Carabantes-Silva R, Mellado M

Open source

DOI: 10.3390/ph19071024
Published: 2026 Jun 30
Container: Pharmaceuticals (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ph19071024,
  title = {Evolution of Multitarget Strategies for Alzheimer's Disease: From Cholinergic Inhibition to Network-Oriented Therapeutic Design (2006-2025).},
  author = {Mella J and Vega-Muñoz A and Soto M and Moraga D and Campanini-Salinas J and Sandoval-Obando E and Contreras-Barraza N and Salazar-Sepúlveda G and Salas-Guzmán N and Carabantes-Silva R and Mellado M},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19071024},
  url = {https://doi.org/10.3390/ph19071024}
}

RIS

TY  - JOUR
TI  - Evolution of Multitarget Strategies for Alzheimer's Disease: From Cholinergic Inhibition to Network-Oriented Therapeutic Design (2006-2025).
AU  - Mella J
AU  - Vega-Muñoz A
AU  - Soto M
AU  - Moraga D
AU  - Campanini-Salinas J
AU  - Sandoval-Obando E
AU  - Contreras-Barraza N
AU  - Salazar-Sepúlveda G
AU  - Salas-Guzmán N
AU  - Carabantes-Silva R
AU  - Mellado M
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19071024
UR  - https://doi.org/10.3390/ph19071024
ER  -

APA

J, M., A, V., M, S., D, M., J, C., E, S., N, C., G, S., N, S., R, C., & M, M. (2026). Evolution of Multitarget Strategies for Alzheimer's Disease: From Cholinergic Inhibition to Network-Oriented Therapeutic Design (2006-2025).. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19071024

Source records

pubmed · retrieved 2026-09-25T08:56:14.935Z